Total Funding
25
56
Total FundingVenture - Series Unknown raised
Growth Score 25 in past quarter
-3 pts
Heat Score 56 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
112162
Protégé Biomedical is a company with a unique new line of hemostatic products developed to stop bleeding in animals and humans*.
About the Company
Protégé Biomedical is a company with a unique new line of hemostatic products developed to stop bleeding in animals and humans*. Their hemostatic devices use a patent-pending compound of all-natural minerals designed to quickly stop bleeding in minor to severe wounds. Protégé Biomedical will launch their first product, ClotIt, in September. ClotIt
is a powder designed to stop bleeding in minor-to-severe animal wounds. *Military, Surgical, and general consumer products are currently in development.
Women Founded
